FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia

NCT00769522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

564

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: Rituximab
DRUG: Bendamustine
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

German CLL Study Group

Collaborators

[object Object]
[object Object]